Cargando…
Calciphylaxis Cutis Associated With Fibroblast Growth Factor Receptor (FGFR) Inhibitor Therapy: A New Challenge
Specific fibroblast growth factor receptor (FGFR) inhibitors have been developed to treat malignancies harboring fusions or rearrangements in FGFR2 or FGFR3. Here, we report a case of calciphylaxis cutis in association with FGFR inhibitor therapy in a patient with FGFR2 rearranged cholangiocarcinoma...
Autores principales: | Griffith, Paige, Jedrych, Jaroslaw, Sunshine, Joel, Laheru, Daniel A, Yarchoan, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860720/ https://www.ncbi.nlm.nih.gov/pubmed/35223258 http://dx.doi.org/10.7759/cureus.21478 |
Ejemplares similares
-
Calciphylaxis After Kidney Transplant
por: Ryan, Michael P, et al.
Publicado: (2019) -
Calciphylaxis: A Deceiving Cellulitis
por: Meegada, Sreenath, et al.
Publicado: (2019) -
Cutis Marmorata
Publicado: (1910) -
Calciphylaxis Secondary to Vitamin D Supplementation
por: Costa e Silva, Joana, et al.
Publicado: (2023) -
Hyperbaric Oxygen Therapy Improving Penile Calciphylaxis
por: Lipinski, Matthew, et al.
Publicado: (2020)